Terms: = Ovarian cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4
26 results:
1. [Signal transducer and activator of transcription 3 and cancer associated fibroblasts jointly generate chemo-resistance and affect prognosis in epithelial ovarian cancer].
Zhang YN; Li B; Li YQ; Liu SH; Hou HY; Wang KY; Ao M; Song Y
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):368-377. PubMed ID: 37217344
[No Abstract] [Full Text] [Related]
2. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in
Philpott S; Raikou M; Manchanda R; Lockley M; Singh N; Scott M; Evans DG; Adlard J; Ahmed M; Edmondson R; Woodward ER; Lamnisos A; Balega J; Brady AF; Sharma A; Izatt L; Kulkarni A; Tripathi V; Solomons JS; Hayes K; Hanson H; Snape K; Side L; Skates S; McGuire A; Rosenthal AN
J Med Genet; 2023 May; 60(5):440-449. PubMed ID: 36319079
[TBL] [Abstract] [Full Text] [Related]
3. Identification of hub pathways and drug candidates in gastric cancer through systems biology.
Salarikia SR; Kashkooli M; Taghipour MJ; Malekpour M; Negahdaripour M
Sci Rep; 2022 Jun; 12(1):9099. PubMed ID: 35650297
[TBL] [Abstract] [Full Text] [Related]
4. A novel diagnostic nomogram based on serological and ultrasound findings for preoperative prediction of malignancy in patients with ovarian masses.
Guo Y; Jiang T; Ouyang L; Li X; He W; Zhang Z; Shen H; You Z; Yang G; Lai H
Gynecol Oncol; 2021 Mar; 160(3):704-712. PubMed ID: 33357959
[TBL] [Abstract] [Full Text] [Related]
5. Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived col1a1 and facilitates ovarian cancer metastasis.
Li M; Wang J; Wang C; Xia L; Xu J; Xie X; Lu W
Exp Cell Res; 2020 Sep; 394(1):112153. PubMed ID: 32589888
[TBL] [Abstract] [Full Text] [Related]
6. Systematic prediction of key genes for ovarian cancer by co-expression network analysis.
Wang M; Wang J; Liu J; Zhu L; Ma H; Zou J; Wu W; Wang K
J Cell Mol Med; 2020 Jun; 24(11):6298-6307. PubMed ID: 32319226
[TBL] [Abstract] [Full Text] [Related]
7. Abl interactor 1: A novel biomarker for osteoporosis in Chinese elderly men.
Zhou X; Li CH; He P; Wu LF; Lu X; Lei SF; Deng FY
J Proteomics; 2019 Sep; 207():103440. PubMed ID: 31325607
[TBL] [Abstract] [Full Text] [Related]
8. Genes involved in hormone metabolism and cellular response in human ovarian granulosa cells.
Brązert M; Iżycki D; Kranc W; Borowiec B; Popis M; Ożegowska K; Bręborowicz A; Rachoń D; Nowicki M; Kempisty B
J Biol Regul Homeost Agents; 2019 Mar-Apr,; 33(2):461-468. PubMed ID: 30968676
[TBL] [Abstract] [Full Text] [Related]
9. Multicenter pre-operative assessment of pediatric ovarian malignancy.
Madenci AL; Vandewalle RJ; Dieffenbach BV; Laufer MR; Boyd TK; Voss SD; Frazier AL; Billmire DF; Rescorla FJ; Weil BR; Weldon CB
J Pediatr Surg; 2019 Sep; 54(9):1921-1925. PubMed ID: 30867096
[TBL] [Abstract] [Full Text] [Related]
10. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
[TBL] [Abstract] [Full Text] [Related]
11. Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
Yang L; Jing J; Sun L; Yue Y
Medicine (Baltimore); 2018 Aug; 97(34):e11895. PubMed ID: 30142790
[TBL] [Abstract] [Full Text] [Related]
12. A gene interaction network‑based method to measure the common and heterogeneous mechanisms of gynecological cancer.
Wang M; Li L; Liu J; Wang J
Mol Med Rep; 2018 Jul; 18(1):230-242. PubMed ID: 29749503
[TBL] [Abstract] [Full Text] [Related]
13. Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral.
Rosenberger LH; Weber R; Sjoberg D; Vickers AJ; Mangino DA; Morrow M; Pilewskie ML
Breast Cancer Res Treat; 2017 Apr; 162(2):275-282. PubMed ID: 28132390
[TBL] [Abstract] [Full Text] [Related]
14. Successful Oocyte Cryopreservation in Reproductive-Aged cancer Survivors.
Druckenmiller S; Goldman KN; Labella PA; Fino ME; Bazzocchi A; Noyes N
Obstet Gynecol; 2016 Mar; 127(3):474-480. PubMed ID: 26855092
[TBL] [Abstract] [Full Text] [Related]
15. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
[TBL] [Abstract] [Full Text] [Related]
16. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
[TBL] [Abstract] [Full Text] [Related]
17. Connecting prognostic ligand receptor signaling loops in advanced ovarian cancer.
Eng KH; Ruggeri C
PLoS One; 2014; 9(9):e107193. PubMed ID: 25244152
[TBL] [Abstract] [Full Text] [Related]
18. Impact of combination chemotherapy with itraconazole on survival for patients with recurrent or persistent ovarian clear cell carcinoma.
Tsubamoto H; Sonoda T; Yamasaki M; Inoue K
Anticancer Res; 2014 Apr; 34(4):2007-14. PubMed ID: 24692739
[TBL] [Abstract] [Full Text] [Related]
19. Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells.
Yu PN; Yan MD; Lai HC; Huang RL; Chou YC; Lin WC; Yeh LT; Lin YW
Int J Cancer; 2014 Feb; 134(3):542-51. PubMed ID: 23904094
[TBL] [Abstract] [Full Text] [Related]
20. FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome.
Quinn MC; Wojnarowicz PM; Pickett A; Provencher DM; Mes-Masson AM; Davis EC; Tonin PN
Int J Oncol; 2013 Mar; 42(3):912-20. PubMed ID: 23354471
[TBL] [Abstract] [Full Text] [Related]
[Next]
